Yu-Jun Dong (Yujun Dong)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Acute Myeloid Leukemia

Infectious Diseases

Newly Diagnosed

Prognostic Factors

Top Venues

Annals of hematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaodi Yang, Jialin Zhu, Qingyun Wang, Bo Tang, Ye Shen, Bingjie Wang, Li Ji, Huihui Liu, Stefan Wuchty, Ziding Zhang, Yu-Jun Dong, Liang Ze-Yin
Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems 9 (6) (2024)
Xiaodi Yang, Jialin Zhu, Qingyun Wang, Bo Tang, Ye Shen, Bingjie Wang, Li Ji, Huihui Liu, Stefan Wuchty, Ziding Zhang, Yu-Jun Dong, Liang Ze-Yin
Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems 9 (6) (2024)
Xiaodi Yang, Jialin Zhu, Qingyun Wang, Bo Tang, Ye Shen, Bingjie Wang, Li Ji, Huihui Liu, Stefan Wuchty, Ziding Zhang, Yu-Jun Dong, Liang Ze-Yin
Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems 9 (6) (2024)
Xiaodi Yang, Jialin Zhu, Qingyun Wang, Bo Tang, Ye Shen, Bingjie Wang, Li Ji, Huihui Liu, Stefan Wuchty, Ziding Zhang, Yu-Jun Dong, Liang Ze-Yin
Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems (2024)
Lu Zhang, Qin-Hua Liu, Hui Zhou, Hui-Lai Zhang, Yu-Jun Dong, Xiao-Bo Wang, Lu-Qun Wang, Li-Ping Su, Xiao-Jing Yan, Yan Li, Ming-Zhi Zhang, Kai-Yang Ding, Hui-Han Wang, Hong-Ling Peng, Li-Ye Zhong, Lin Yang, Lin-Tao Bi, Da Gao, Guang-Xun Gao, Liang Huang, Chun-Yan Sun, Jia Song, Wenbin Qian, Wen-Rong Huang, Zhen-Ling Li, Yao Liu, Jian Li
Asymptomatic multicentric Castleman disease: A potential early stage of idiopathic MCD. Blood advances (2024)
Xiaodi Yang, Jialin Zhu, Qingyun Wang, Bo Tang, Ye Shen, Bingjie Wang, Li Ji, Huihui Liu, Stefan Wuchty, Ziding Zhang, Yu-Jun Dong, Liang Ze-Yin
Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems 9 (6) (2024)
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yu-Jun Dong
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of hematology (2023)
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yu-Jun Dong
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of hematology 102 (4) (2023)
Yuan Jian, Long Chang, Ming-Xia Shi, Ying Sun, Xiao-Xia Chu, Hua Xue, Wen-Rong Huang, Xu-Liang Shen, Jie Ma, Guo-Rong Jia, Ya-Qing Feng, Zhen-Fang Xi, Yan-Hong Zhao, Yan-Ping Ma, Jing Xiao, Guang-Yu Ma, Qing-Ming Wang, Li Bao, Yu-Jun Dong, He-Bing Zhou, Chunyan Sun, Guo-Hong Su, Yan Yan, Sai-Yin Qimuge, Li-Ping Su, Jing-Nan Sun, Wei-Wei Tian, Xiu-Li Sun, Hong-Mei Jing, Da Gao, Wen-Ming Chen, Jian Li, Wen Gao
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood advances (2023)
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yu-Jun Dong
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of hematology 102 (4) (2023)
Weiwei Xie, Qian Wang, Fude Zhou, Suxia Wang, Yuhua Sun, Xinan Cen, Hanyun Ren, Zhixiang Qiu, Yu-Jun Dong
Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study. International journal of hematology (2023)
Ping Yang, Qing-Qing Cai, Wei Zhang, Shuo-Zi Liu, Hui Liu, Xiu-Hua Sun, Yu-Jun Dong, Xiu-Bin Xiao, Jing-Wen Wang, Zhen-Ling Li, Wen-Rong Huang, Li-Hong Li, Hui-Zheng Bao, Wei Yang, Ya-Lan Wang, Shu-Ye Wang, Juan He, Xiao-Ling Li, Ai-Chun Liu, Hong-Mei Jing
Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis. Cancer medicine (2023)
Yamei Zhai, Qingya Wang, Li Ji, Hanyun Ren, Yu-Jun Dong, Fan Yang, Yue Yin, Zeyin Liang, Qian Wang, Wei Liu, Yan Mei, Lu Zhang, Yuan Li
Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world. Cancer medicine (2023)
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yu-Jun Dong
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of hematology 102 (4) (2023)
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yu-Jun Dong
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of hematology (2023)
Weiwei Xie, Zeyin Liang, Qian Wang, Bingjie Wang, Yue Yin, Yuan Li, Hanyun Ren, Yu-Jun Dong
An adult case of systemic lupus erythematosus and cerebral vasculitis after umbilical cord blood transplantation for acute myeloid leukemia. Annals of hematology (2023)
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yu-Jun Dong
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of hematology (2023)
Li Bao, Ai-Jun Liu, Bin Chu, Qian Wang, Yu-Jun Dong, Min-Qiu Lu, Lei Shi, Shan Gao, Yu-Tong Wang, Li-Fang Wang, Wen-Ming Chen, Jun-Ling Zhuang
Front-line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real-world setting: A multicenter retrospective study in China. Cancer medicine (2022)
Lu Zhang, Miao-Yan Zhang, Xin-Xin Cao, Dao-Bin Zhou, David C Fajgenbaum, Yu-Jun Dong, Jian Li
A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory iMCD. Leukemia & lymphoma 63 (3) (2022)
Miao Yan, Huihui Liu, Junhui Xu, Xinan Cen, Qian Wang, Weilin Xu, Wensheng Wang, Zhixiang Qiu, Jinping Ou, Yu-Jun Dong, Ping Zhu, Hanyun Ren, Fuchu He, Mangju Wang
Expression of human Krüppel-like factor 3 in peripheral blood as a promising biomarker for acute leukemia. Cancer medicine 9 (8) (2020)
Zhenhua Wang, Yongjin Shi, Huihui Liu, Zeyin Liang, Qiang Zhu, Lihong Wang, Bo Tang, Shengchao Miao, Ning Ma, Xinan Cen, Hanyun Ren, Yu-Jun Dong
Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion. Hematological oncology 37 (5) (2019)